SCHEDULE: Aaron Rollins Discloses 20.9% Stake in AirSculpt

Dr. Aaron Rollins has filed a Schedule 13G reporting beneficial ownership of 14,721,062 shares of AirSculpt Technologies, Inc.

Summary

• Dr. Aaron Rollins reports beneficial ownership of 14,721,062 shares of AirSculpt Technologies, Inc. common stock.
• This holding represents 20.9% of the company's total outstanding shares.
• The calculation is based on 70,545,681 shares outstanding as of May 7, 2026.
• Dr. Rollins maintains sole voting and dispositive power over the reported shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure confirming existing ownership levels without indicating new strategic shifts.

Positives

• Significant insider ownership indicates strong alignment between the reporting person and shareholder interests.

Negatives

• None identified in this regulatory disclosure.

Risks

• Concentrated ownership by a single individual may influence corporate decision-making processes.

Future Outlook

No forward-looking guidance or strategic outlook provided in this ownership disclosure.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard regulatory requirements for significant shareholders and do not inherently signal a change in company strategy or operational performance.

Comparison to Industry Standards

• High insider ownership is common in founder-led growth companies within the medical aesthetics sector.
• The disclosure aligns with standard SEC reporting requirements for individuals exceeding the 5% ownership threshold.

Stakeholder Impact

• Provides transparency to shareholders regarding the concentration of voting power held by Dr. Rollins.

Next Steps

• Continued monitoring of future SEC filings for any changes in beneficial ownership or insider trading activity.

Key Dates

Keywords

AirSculpt Technologies, Schedule 13G, Aaron Rollins, Beneficial Ownership, Insider Holdings